WHAT IS #ONLYMENCAN?
Whilst plenty of campaigns are dedicated for women, we decided to initiate an awareness
campaign focusing on Malaysian men — since prostate cancer is a silent killer that
impacts Only Men.
Prostate cancer is a silent killer that
impacts Only Men.
In Malaysia, more than 60% of prostate cancer cases are diagnosed at an advanced stage. We want to raise awareness on the importance of prostate health, risks and symptoms of prostate cancer and encourage early detection of prostate cancer in order to save our men.
There are things #OnlyMenCan do, like surviving prostate cancer — only if detected and treated early.
Vision & Mission
We aim to halve the number of newly-diagnosed advanced prostate cancer cases in Malaysia, from over 60% in 2020 to 30% by 2025.
To achieve this goal, we are committed to raising national awareness about prostate cancer, enhancing the competency of our healthcare professionals, and encouraging early detection and treatment.
The Urological Cancer Trust Fund is a non-
profit entity under the Faculty of Medicine,
Universiti Malaya.
Set up in 2015, the Fund is committed to increasing public awareness of urological
cancers particularly prostate cancer, encouraging early detection of prostate
cancer, and providing financial assistance to under-privileged patients.
“With increased awareness of early detection, our men
will have a better chance of surviving prostate cancer.”
Professor Dato Dr Adeeba Kamarulzaman
Universiti Malaya, and Chairperson of the Urological Cancer Trust Fund. As
President of International AIDS Society, she has used her clinical and academic
leadership to engage in the national and community response to HIV/AID in
Malaysia – she aspires to do the same for prostate cancer in Malaysia.
“So many men suffer terribly because of this illness. I
survived and I want to help others combat prostate cancer.”
Dato' Tan Sri Nazir Razak
prostate cancer survivor. He hopes more men who are at risk for prostate
cancer will seek early detection and treatment, because Only Men can survive
prostate cancer. He joined the Board of Trustees for the Urological Cancer
Trust Fund in August 2020.